NORTHERN CALIFORNIA CANCER PROGRAM CCOP RESEARCH BASE
北加州癌症计划 CCOP 研究基地
基本信息
- 批准号:3558156
- 负责人:
- 金额:$ 6.42万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1983
- 资助国家:美国
- 起止时间:1983-09-30 至 1990-05-31
- 项目状态:已结题
- 来源:
- 关键词:Hodgkin's disease antineoplastics brain neoplasms cancer information system cancer registry /resource cancer rehabilitation /care cancer risk community health services continuing education eye neoplasms gastrointestinal neoplasms head /neck neoplasm health science research analysis /evaluation human subject metastasis neoplasm /cancer education neoplasm /cancer radiation therapy neoplasm /cancer therapy patient /disease registry patient care planning pharmacy administration reproductive system neoplasm urinary tract neoplasms
项目摘要
The Northern California Cancer Program (NCCP) is the NCI-
designated consortium cancer center for the Northern California
and Northwestern Nevada regions. The Northern California
Oncology Group (NCOG) is an integral component of NCCP,
deriving its personnel and resources form three of NCCP's five
major scientific programs (clinical research, biostatistics and
cancer control). NCOG has established an excellent track record
over more than a decade of conducting innovative cancer clinical
trials, with effective cooperation between academic institutions
and community hospitals.
The NCCP proposes to serve as a cancer treatment and cancer
control research base for the four affiliated CCOP institutions in
Northern California and Northwestern Nevada and as a cancer
control research base for other non-CCOP institutions in this
same region. Through the NCOG clinical trials program, the
NCCP will provide CCOP institutions with access to innovative
Phase II and III treatment protocols for patients with head and
neck cancer, genitourinary cancer, gastrointestinal cancer, brain
tumors, ocular melanoma, Hodgkin's disease and other selected
neoplasms. Through this same clinical trials program, the NCCP
will provide both CCOP and non-CCOP institutions with access to
innovative Phase II and III cancer control protocols designed to:
a) improve the quality of life and to assess/reduce the incidence
of secondary cancers in patients with selected primary neoplasms;
or b) assess/reduce the risk of primary cancer among individuals
at high risk for the development of malignancy.
北方加州癌症计划(NCCP)是NCI-
北方加州指定联合癌症中心
和西北部内华达州地区。 北方加州
肿瘤组(NCOG)是NCCP的一个组成部分,
其人员和资源来自NCCP的五个中的三个
主要科学项目(临床研究、生物统计学和
癌症控制)。 NCOG已经建立了一个优秀的记录
十多年来,我们致力于开展创新的癌症临床研究,
在学术机构之间的有效合作下,
和社区医院。
NCCP建议作为癌症治疗和癌症
CCOP下属四个机构的控制研究基地,
北方加州和西北部内华达州和作为一个癌症
控制研究基地,为其他非CCOP机构在这方面
同一地区。 通过NCOG临床试验计划,
NCCP将为CCOP机构提供创新的
II期和III期治疗方案,用于患有头部和
颈部癌症、泌尿生殖系统癌症、胃肠道癌症、脑癌
肿瘤、眼黑色素瘤、霍奇金病和其他选定的
肿瘤。 通过同样的临床试验项目,NCCP
将为CCOP和非CCOP机构提供以下机会:
创新的II期和III期癌症控制方案旨在:
(a)提高生活质量,评估/降低发病率
患有选定原发性肿瘤的患者的继发性癌症;
或B)评估/降低个体中原发性癌症的风险
恶性肿瘤的高风险。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Theodore Phillips其他文献
Theodore Phillips的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Theodore Phillips', 18)}}的其他基金
RESEARCH BASE FOR SAN JOAQUIN VALLEY COMMUNITY CLINICAL
圣华金谷社区临床研究基地
- 批准号:
3558157 - 财政年份:1983
- 资助金额:
$ 6.42万 - 项目类别:
RESEARCH BASE FOR SAN JOAQUIN VALLEY COMMUNITY CLINICAL
圣华金谷社区临床研究基地
- 批准号:
3558158 - 财政年份:1983
- 资助金额:
$ 6.42万 - 项目类别:
NORTHERN CALIFORNIA CANCER PROGRAM CCOP RESEARCH BASE
北加州癌症计划 CCOP 研究基地
- 批准号:
3558159 - 财政年份:1983
- 资助金额:
$ 6.42万 - 项目类别:
相似海外基金
The analysis of proteinuria caused by antineoplastics and the preventative effects with antihypertensive medications using the Japanese medical database
利用日本医学数据库分析抗肿瘤药物引起的蛋白尿及抗高血压药物的预防效果
- 批准号:
21K17258 - 财政年份:2021
- 资助金额:
$ 6.42万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Expediting Drug Development by Profiling Novel Antineoplastics by Mass Spectrometry-based Biomarker Profiling
通过基于质谱的生物标志物分析来分析新型抗肿瘤药物,加速药物开发
- 批准号:
499958-2016 - 财政年份:2016
- 资助金额:
$ 6.42万 - 项目类别:
Engage Grants Program
Combinatorial Peptidomimetics as Antineoplastics
作为抗肿瘤药的组合肽模拟物
- 批准号:
6623455 - 财政年份:2002
- 资助金额:
$ 6.42万 - 项目类别:
Combinatorial Peptidomimetics as Antineoplastics
作为抗肿瘤药的组合肽模拟物
- 批准号:
6465958 - 财政年份:2002
- 资助金额:
$ 6.42万 - 项目类别:
Novel Nanoparticle Delivery System for Antineoplastics
新型抗肿瘤纳米颗粒输送系统
- 批准号:
6483914 - 财政年份:2002
- 资助金额:
$ 6.42万 - 项目类别:
GLYCOLIPIDS AND CYTOTOXIC RESPONSE TO ANTINEOPLASTICS
糖脂和抗肿瘤药物的细胞毒性反应
- 批准号:
6124630 - 财政年份:1998
- 资助金额:
$ 6.42万 - 项目类别:
GLYCOLIPIDS AND CYTOTOXIC RESPONSE TO ANTINEOPLASTICS
糖脂和抗肿瘤药物的细胞毒性反应
- 批准号:
6329037 - 财政年份:1998
- 资助金额:
$ 6.42万 - 项目类别:
GLYCOLIPIDS AND CYTOTOXIC RESPONSE TO ANTINEOPLASTICS
糖脂和抗肿瘤药物的细胞毒性反应
- 批准号:
2747737 - 财政年份:1998
- 资助金额:
$ 6.42万 - 项目类别:
POLYMORPHIC METABOLISM OF ANTINEOPLASTICS IN CHILDREN
儿童抗肿瘤药物的多态性代谢
- 批准号:
3459680 - 财政年份:1990
- 资助金额:
$ 6.42万 - 项目类别:
POLYMORPHIC METABOLISM OF ANTINEOPLASTICS IN CHILDREN
儿童抗肿瘤药物的多态性代谢
- 批准号:
3459678 - 财政年份:1990
- 资助金额:
$ 6.42万 - 项目类别: